Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto's thyroiditis compared to non-autoimmune thyroid disease and healthy controls

Hormones

Volumn 13, Issue 3, 2014, Pages 338-344

  Ruggeri, Rosaria Maddalena ^a   Minciullo, Paola ^b   Saitta, Salvatore ^b   Giovinazzo, Salvatore ^a   Certo, Rosaria ^a   Campennì, Alfredo ^a   Trimarchi, Francesco ^a   Gangemi, Sebastiano ^b   Benvenga, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Autoimmune thyroid disease; Cytokines; Hashimoto's thyroiditis; Interleukin 22; Lymphocytes T Helper 17 and 22 (Th17 and Th22)

Indexed keywords

INTERLEUKIN 22; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; BIOLOGICAL MARKER; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; THYROID HORMONE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; ELISA KIT; EUTHYROIDISM; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; ONSET AGE; PROTEIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GOITER, NODULAR; HELPER CELL; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PREDICTIVE VALUE; UPREGULATION; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GOITER, NODULAR; HASHIMOTO DISEASE; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; T-LYMPHOCYTES, HELPER-INDUCER; THYROID HORMONES; UP-REGULATION; YOUNG ADULT;

EID: 84904578659     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1483     Document Type: Article

References (40)

1. Brent gA, Davies TF 2012 Hypothyroidism and thyroiditis. in: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) 12th edition Williams Textbook of endocrinology, Saunders, Philadelphia; pp, 423-456.
2. Benvenga S, Trimarchi F, 2008 Changed presentation of Hashimoto's thyroiditis in North-eastern Sicily and Calabria (Southern italy) based on a 31-year experience. Thyroid 18: 429-441.
3. Weetman AP, 2004 Cellular immune responses in autoimmune thyroid disease. Clin endocrinol (Oxf) 61: 405-413.
4. Fountoulakis S, Tsatsoulis A, 2004 On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin endocrinol 60: 397-409.
5. Peterson RA, 2012 Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 40: 186-204.
6. Fountoulakis S, Vartholomatos g, Kolaitis N, Frillingos S, Philippou g, Tsatsoulis A, 2008 HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid 18: 1195-1200.
7. Mazziotti g, Sorvillo F, Naclerio C, et al, 2003 Type-1 response in peripheral CD4+ and CD8+ T cells from patients with Hashimoto's thyroiditis. eur J endocrinol 148: 383-388.
8. Phenekos C, Vryonidou A, gritzapis AD, Baxevanis CN, goula M, Papamichail M, 2004 Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and graves' disease (Th2). Neuroimmunomodulation 11: 209-213.
9. Paschke R, Schuppert F, Taton M, Velu T, 1994 intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J endocrinol 141: 309-315.
10. Fisfalen Me, Palmer eM, Van Seventer gA, et al, 1997 Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin endocrinol Metab 82: 3655-3663.
11. Horie i, Abiru N, Nagayama Y, et al, 2009 T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in non-obese diabetic-H2h4 mice. endocrinology 150: 5135-5142.
12. Nanba T, Watanabe M, inoue N, iwatani Y, 2009 increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable graves' disease. Thyroid 19: 495-501.
13. Shi Y, Wang H, Su Z, et al, 2010 Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand J immunol 72: 250-255.
14. Figueroa-Vega N, Alfonso-Pérez M, Benedicto i, Sánchez-Madrid F, gonzález-Amaro R, Marazuela M, 2010 increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin endocrinol Metab 95: 953-962.
15. Afzali B, Lombardi g, Lechler Ri, Lord gM, 2007 The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin exp immunol 148: 32-46.
16. Kolls JK, Khader SA, 2010 The role of Th17 cytokines in primary mucosal immunity. Cytokine growth Factor Rev 21: 443-448.
17. Aujla SJ, Kolls JK, 2009 iL-22: a critical mediator in mucosal host defense. J Mol Med (Berl) 87: 451-454.
18. eyerich S, eyerich K, Cavani A, Schmidt-Weber C, 2010 iL-17 and iL-22: siblings, not twins. Trends immunol 31: 354-361.
19. Witte e, Witte K, Warszawska K, Sabat R, Wolk K, 2010 interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. Cytokine growth Factor Rev 21: 365-379.
20. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA, 2009 Anti-inflammatory and pro-inflammatory roles of TgF-b, iL-10, and iL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9: 447-453.
21. Wolk K, Witte e, Witte K, Warszawska K, Sabat R, 2010 Biology of interleukin-22. Semin immunopathol 32: 17-31.
22. eyerich S, eyerich K, Pennino D, et al, 2009 Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin invest 119: 3573-3585.
23. Yang XY, Wang HY, Zhao XY, Wang LJ, Lv QH, Wang QQ, 2013 Th22, but not Th17 Might be a good index to Predict the Tissue involvement of Systemic Lupus erythematosus. J Clin immunol 33: 767-774.
24. Pan HF, Zhao XF, Yuan H, et al, 2009 Decreased serum iL-22 levels in patients with systemic lupus erythematosus. Clinica Chimica Acta 401: 179-180.
25. ikeuchi H, Kuroiwa T, Hiramatsu N, et al, 2005 expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 52: 1037-1046.
26. Cheng F, guo Z, Xu H, Yan D, Li Q, 2009 Decreased plasma iL22 levels, but not increased iL17 and iL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Diseases 68: 604-606.
27. da Rocha Jr LF, Duarte AL, Dantas AT, et al, 2012 increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J Rheumatol 39: 1320-1325.
28. Leipe J, Schramm MA, grunke M, et al, 2011 interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 70: 1453-1457.
29. Mitra A, Raychaudhuri SK, Raychaudhuri SP, 2012 Functional role of iL-22 in psoriatic arthritis. Arthritis Res Ther 14: R65.
30. Pan HF, Li XP, Zheng Sg, Ye DQ, 2013 emerging role of interleukin-22 in autoimmune diseases. Cytokine growth Factor Rev 24: 51-57.
31. Semerano L, Assier e, Boissier MC, 2012 Anti-cytokine vaccination: a new biotherapy of autoimmunity? Autoimmun Rev 11: 785-786.
32. Ke Y, Sun D, Jiang g, Kaplan HJ, Shao H, 2011 iL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J immunol 187: 2130-2139.
33. Pedersen OM, Aardal NP, Larssen TB, Varhaug Je, Myking O, Vik-Mo H, 2000 The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 10: 251-259.
34. Rago T, Chiovato L, grasso L, Pinchera A, Vitti P, 2001 Thyroid ultrasonography as a tool for detecting thyroid autoimmune diseases and predicting thyroid dysfunction in apparently healthy subjects. J endocrinol invest 24: 763-769.
35. Vejbjerg P, Knudsen N, Perrild H, et al, 2006 The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. eur J endocrinol 155: 547-552.
36. Ruggeri RM, Villari D, Simone A, et al, 2002 Coexpression of interleukin-6 (iL-6) and interleukin-6 receptor (iL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor. J endocrinol invest 25: 959-966.
37. Ruggeri RM, Barresi g, Sciacchitano S, Trimarchi F, Benvenga S, Trovato M, 2006 immunoexpression of the CD30 ligand/CD30 and iL-6/iL-6R signals in thyroid autoimmune diseases. Histol Histopathol 21: 249-256.
38. Ruggeri RM, Sciacchitano S, Vitale A, et al, 2009 Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals. J endocrinol invest 32: 465-469.
39. Zhang N, Pan HF, Ye DQ, 2011 Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Molecular and Cellular Biochemistry 353: 41-46.
40. gopalakrishnan S, Sen S, Adhikari JS, Chugh PK, Sekhri T, Rajan S, 2010 The role of T-lymphocyte subsets and interleukin-5 blood levels among indian subjects with autoimmune thyroid disease. Hormones (Athens) 9: 76-81.